Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Asia Pacific Autoimmune Disorders Treatment Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets

Research and Markets
Posted on: 16 Nov 16

Research and Markets has announced the addition of the "Asia Pacific Autoimmune Disorders Treatment Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.

Key market players of Asia pacific autoimmune disorders treatment market includes, Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Johnson & Johnson, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Sanofi, Merck, and Pfizer Inc. Recently, Abbott has announced Thyroid Awareness Initiative in India, which aimed at greater understanding of thyroid disorder that would amplify the access to its diagnosis.


  • Deep-dive analysis of different segment as applications, products, services, technologies and geography for Asia Pacific autoimmune disorders treatment market provides the key insights of multiple segments
  • In-depth analysis of various geographies would give an understanding of the trends in various regions so that companies can make country specific plans
  • The projections in the report are made by analyzing the current market trends and future market potential for the period of 2014-2020 in terms of value
  • Comprehensive assessment of Asia pacific autoimmune disorders treatment market including drivers, restrains and opportunities would assist professionals to understand the market behavior
  • Competitive landscape includes the leaders for within Asia pacific region for the autoimmune treatment market with key strategies adopted by them to achieve high monetary value
  • Market attractiveness analysis for the Asia Pacific autoimmune treatment market provides strategic assistance to decision makers
  • Ease of doing business analysis should help in making strategic business decisions



Therapeutic drug Products

  • Immunosuppressant
  • Anti-inflammatory drugs
  • Anti-cancer drugs
  • Anti- malarial drugs
  • DMARDs
  • oNSAIDs
  • Biologics

Therapeutic equipment

  • Diagnostic equipment
  • Therapeutic and monitoring equipment


  • Bridge therapy
  • Recombinant technology
  • Fecal bacteriotherapy
  • Hematopoietic stem-cell transplantation
  • Phototherapy
  • Helminthic therapy
  • Activation-induced assays
  • Cytometry by time-of-flight mass spectrometry


  • Systemic autoimmune diseases (involve several organs of the body)
  • Localized autoimmune diseases (involve single organ)


  • Consultation & Diagnosis
  • Therapy & Monitoring
  • Drug Development

For more information about this report visit

View source version on

Business Wire

Last updated on: 16/11/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.